J. Hilgers et al., QUANTITATION OF POLYMORPHIC EPITHELIAL MUCIN - A CHALLENGE FOR BIOCHEMISTS AND IMMUNOLOGISTS, Scandinavian journal of clinical & laboratory investigation, 55, 1995, pp. 81-86
Polymorphic epithelial mucin (PEM) is a heavily glycosylated protein p
resent at the apical surface of glandular epithelial cells which is sh
ed into the lumen of epithelial tissue. In carcinomas cell polarisatio
n is lost, PEM is overexpressed and found on the entire cell surface.
High amounts of PEM are shed into the circulation of cancer patients.
CA 15.3 is the first commercial assay for the detection of PEM. After
roughly one decade of use in clinical practice it is considered valuab
le for breast cancer therapy monitoring and, in the follow up, for ear
ly detection of metastatic disease. The extreme polymorphism of this m
olecule, with its varying number of multiple epitopes and tremendous v
ariation in glycosylation which can mask catcher/tracer epitopes, impa
irs its precise measurement. A further impediment is complex formation
with autoantibodies, as revealed by a recently developed assay.